CIK 0001124105 · Accelerated filer<br>Smaller reporting company
GYRE THERAPEUTICS, INC.
Sign in to watch- Ticker
- GYRE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 562020050
- Phone
- (858) 284-0115
- Business address
- 12730 HIGH BLUFF DRIVE, SUITE 250, SAN DIEGO, CA, 92130
- Former names
- CATALYST BIOSCIENCES, INC., TARGACEPT INC
- 10-Q Report Quarterly Report
- 4 Insider Changes in Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- SCHEDULE 13D/A Stake Beneficial Ownership Report
- 8-K Event Results of operations
- SCHEDULE 13D/A Stake Beneficial Ownership Report
- SCHEDULE 13D/A Stake Beneficial Ownership Report
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- DEFA14A Proxy Proxy Materials
- 8-K Event Acquisition or sale completed · Unregistered share sale · Shareholder rights changed · Executive or director change · Bylaws or fiscal year change · Regulation FD disclosure
- ARS Other Annual Report to Security Holders
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- 8-K/A Event Material agreement
- PRE 14A Proxy Proxy Statement (Preliminary)
- 8-K Event Other events
Page 3 of 81 · 1,604 filings